REQUEST A DEMO
Total
USD $0.00
Search more companies

Rahavard Tamin Pharmaceutical Public Joint Stock Company (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rahavard Tamin Pharmaceutical Public Joint Stock Company Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rahavard Tamin Pharmaceutical Company is a producer of vinyl pyrrolidone homopolymers (PVP) and their derivatives in the Middle East, which has been supplying its products since 2004. Production of PVP material started in the first trial in the country in 2002. Due to the production of this highly desirable quality material, Rahavard Tamin Pharmaceutical Company is now a rival of similar foreign products, especially in European countries, and effective steps have been taken to export this substance to all parts of the world.

Headquarters
18 Km Of Special Road, Darupakhsh St, Farvardin Som St, Door Number Five
Tehran; Tehran;

Contact Details: Purchase the Rahavard Tamin Pharmaceutical Public Joint Stock Company report to view the information.

Website: http://www.rtpvp.com

Basic Information
Total Employees:
Purchase the Rahavard Tamin Pharmaceutical Public Joint Stock Company report to view the information.
Outstanding Shares:
Purchase the Rahavard Tamin Pharmaceutical Public Joint Stock Company report to view the information.
Financial Auditors:
Purchase the Rahavard Tamin Pharmaceutical Public Joint Stock Company report to view the information.
Incorporation Date:
2004
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Rahavard Tamin Pharmaceutical Public Joint Stock Company report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
86.39%
Total operating revenue
86.39%
Operating profit (EBIT)
60.52%
EBITDA
60.29%
Net Profit (Loss) for the Period
64.25%
Total assets
88.42%
Total equity
57.36%
Operating Profit Margin (ROS)
-7.92%
Net Profit Margin
-5.25%
Return on Equity (ROE)
3.54%
Debt to Equity Ratio
5.97%
Quick Ratio
0.09%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?